• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Location, incidence, and malignant potential of duodenal gastrinomas.

作者信息

Thom A K, Norton J A, Axiotis C A, Jensen R T

机构信息

Surgical Metabolism Section, National Cancer Institute/NIH, Bethesda, MD 20892.

出版信息

Surgery. 1991 Dec;110(6):1086-91; discussion 1091-3.

PMID:1745977
Abstract

Duodenal gastrinomas are increasingly found at surgery, yet information about their location and characteristics is based on the results of either pooled series or retrospective reviews of small numbers of selected cases. To address these issues we have analyzed the location, incidence, and malignant potential of duodenal gastrinomas in 65 consecutive patients who underwent removal of all tumor as part of a 10-year prospective study to resect gastrinomas in patients with sporadic Zollinger-Ellison syndrome. The primary gastrinoma was located in the duodenum in 24 patients (37%). There were 19 men and five women aged 32 to 69 years (mean 49.4 years), with symptoms for 0.6 to 35 years (mean 7.9 years). Preoperative studies included serum gastrin levels of 114 to 35,798 pg/ml (mean 2060 pg/ml), basal acid output of 7 to 95 mEq/hr (mean 37.6 mEq/hr), and a positive secretin test result in 22 patients. Preoperative imaging studies identified tumor in the duodenal area in 11 patients (46%), but most positive imaging findings were metastatic gastrinoma in lymph nodes, and the primary duodenal tumor itself was identified in only two patients. Portal venous sampling had a localizing gastrin gradient in the inferior or superior pancreaticoduodenal vein in 17 of 23 patients (74%). Each of the 24 patients had a single, small duodenal wall tumor of 2.8 to 10.1 mm diameter (mean 6 mm). Each tumor stained positive for gastrin by immunohistochemistry. Seventeen tumors (71%) were located in the first portion of the duodenum, five (21%) in the second, and two (8%) in the third. Each tumor originated in the submucosa, and 13 (54%) were limited to the submucosa, whereas 11 (46%) were locally invasive, four (16%) extending into the muscularis mucosa and seven (29%) into the muscularis propria. Thirteen patients (54%) had spread to regional lymph nodes, whereas two (8%) had liver metastases. Lymph node metastases were seen with larger duodenal tumors (mean 7.1 vs 5.4 mm; p less than 0.01). The data suggest that a single duodenal wall gastrinoma is a common cause of Zollinger-Ellison syndrome (37%). These small (less than 1 cm) tumors are located in the submucosal layer of the proximal duodenum (92%) and are malignant more often than previously thought (54%).

摘要

相似文献

1
Location, incidence, and malignant potential of duodenal gastrinomas.
Surgery. 1991 Dec;110(6):1086-91; discussion 1091-3.
2
Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.
Surgery. 1992 Dec;112(6):1002-8; discussion 1008-9.
3
Management and outcome of patients with sporadic gastrinoma arising in the duodenum.十二指肠散发性胃泌素瘤患者的管理与预后
Ann Surg. 2003 Jul;238(1):42-8. doi: 10.1097/01.SLA.0000074963.87688.31.
4
Duodenal microgastrinomas associated with Zollinger-Ellison syndrome.
Hepatogastroenterology. 1996 Nov-Dec;43(12):1465-9.
5
Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.胃泌素瘤患者生长抑素受体闪烁扫描术的前瞻性研究及其对手术结果的影响。
Ann Surg. 1998 Aug;228(2):228-38. doi: 10.1097/00000658-199808000-00013.
6
Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.卓-艾综合征的根治性切除术。一项为期10年的前瞻性研究结果。
Ann Surg. 1992 Jan;215(1):8-18. doi: 10.1097/00000658-199201000-00012.
7
Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.十二指肠胃泌素瘤、十二指肠切开术及十二指肠探查在卓-艾综合征外科治疗中的应用
World J Surg. 1993 Jul-Aug;17(4):455-62. doi: 10.1007/BF01655104.
8
Duodenal gastrinoma--clinical features and usefulness of selective arterial secretin injection test.十二指肠胃泌素瘤——临床特征及选择性动脉注射促胰液素试验的应用价值
J Gastroenterol. 1998 Oct;33(5):728-33. doi: 10.1007/s005350050163.
9
Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.1型多发性内分泌腺瘤病和卓-艾综合征患者十二指肠中的胃泌素瘤。
N Engl J Med. 1990 Mar 15;322(11):723-7. doi: 10.1056/NEJM199003153221103.
10
Outcome of surgical treatment for extrapancreatic gastrinomas.胰腺外胃泌素瘤的外科治疗结果
Surg Gynecol Obstet. 1993 Aug;177(2):153-7.

引用本文的文献

1
Long-Term Proton Pump Inhibitor-Acid Suppressive Treatment Can Cause Vitamin B Deficiency in Zollinger-Ellison Syndrome (ZES) Patients.长期质子泵抑制剂抑酸治疗可导致 Zollinger-Ellison 综合征(ZES)患者维生素 B 缺乏。
Int J Mol Sci. 2024 Jul 2;25(13):7286. doi: 10.3390/ijms25137286.
2
Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.卓-艾综合征(ZES)胃酸分泌过多的终身/长期成功医学治疗:神话还是现实?来自美国国立卫生研究院ZES长期前瞻性研究结果分析的见解
Cancers (Basel). 2023 Feb 21;15(5):1377. doi: 10.3390/cancers15051377.
3
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies.
晚期胰腺神经内分泌肿瘤患者接受药物/放射/肝脏靶向抗肿瘤治疗后耐药性疾病的预测因素:最新进展与争议
Cancers (Basel). 2022 Feb 28;14(5):1250. doi: 10.3390/cancers14051250.
4
Giant retroperitoneal lymph node-an uncommon presentation of duodenal neuroendocrine tumour.巨大腹膜后淋巴结——十二指肠神经内分泌肿瘤的一种不常见表现。
BMJ Case Rep. 2021 Jul 21;14(7):e243048. doi: 10.1136/bcr-2021-243048.
5
Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.功能性神经内分泌肿瘤综合征治疗的当前药物治疗策略展望。
Expert Opin Pharmacother. 2021 Apr;22(6):685-693. doi: 10.1080/14656566.2020.1845651. Epub 2020 Nov 11.
6
Gastrointestinal neuroendocrine tumors in 2020.2020年的胃肠道神经内分泌肿瘤
World J Gastrointest Oncol. 2020 Aug 15;12(8):791-807. doi: 10.4251/wjgo.v12.i8.791.
7
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.基于 Zollinger-Ellison 综合征患者研究的对慢性高胃泌素血症和终身质子泵抑制剂治疗的影响/风险的深入了解。
Int J Mol Sci. 2019 Oct 16;20(20):5128. doi: 10.3390/ijms20205128.
8
Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.《Zollinger-Ellison 综合征的外科治疗:经典观点与当前争议》。
World J Gastroenterol. 2019 Aug 28;25(32):4673-4681. doi: 10.3748/wjg.v25.i32.4673.
9
Gastrinomas: Medical or Surgical Treatment.胃泌素瘤:医学或手术治疗。
Endocrinol Metab Clin North Am. 2018 Sep;47(3):577-601. doi: 10.1016/j.ecl.2018.04.009.
10
Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.胰腺神经内分泌肿瘤的影像学:最新进展、现状和争议。
Expert Rev Anticancer Ther. 2018 Sep;18(9):837-860. doi: 10.1080/14737140.2018.1496822. Epub 2018 Jul 17.